Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18366072rdf:typepubmed:Citationlld:pubmed
pubmed-article:18366072lifeskim:mentionsumls-concept:C0007578lld:lifeskim
pubmed-article:18366072lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:18366072lifeskim:mentionsumls-concept:C1512665lld:lifeskim
pubmed-article:18366072lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:18366072lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:18366072lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:18366072lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:18366072pubmed:issue3lld:pubmed
pubmed-article:18366072pubmed:dateCreated2008-6-23lld:pubmed
pubmed-article:18366072pubmed:abstractTextImmunoglobulin (Ig) superfamily members are abundant with diverse functions including cell adhesion in various tissues. Here, we identified and characterized a novel adhesion molecule that belongs to the CTX protein family and named as DICAM (Dual Ig domain containing cell adhesion molecule). DICAM is a type I transmembrane protein with two V-type Ig domains in the extracellular region and a short cytoplasmic tail of 442 amino acids. DICAM is found to be expressed ubiquitously in various organs and cell lines. Subcellular localization of DICAM was observed in the cell-cell contact region and nucleus of cultured epithelial cells. Cell-cell contact region was colocalized with tight junction protein, ZO-1. The DICAM increased MDCK cell adhesion to 60% levels of fibronectin. DICAM mediated cell adhesion was specific for the alphavbeta3 integrin; other integrins, alpha2, alpha5, beta1, alpha2beta1, alpha5beta1, were not involved in cell adhesion. In identifying the interacting domain of DICAM with alphavbeta3, the Ig domain 2 showed higher cell adhesion activity than that of Ig domain 1. Although RGD motif in Ig domain 2 was engaged in cell adhesion, it was not participated in DICAM-alphavbeta3 mediated cell adhesion. Furthermore, differentially expressing DICAM stable cells showed well correlated cell to cell adhesion capability with integrin beta3-overexpressing cells. Collectively, these results indicate that DICAM, a novel dual Ig domain containing adhesion molecule, mediates cell adhesion via alphavbeta3 integrin.lld:pubmed
pubmed-article:18366072pubmed:languageenglld:pubmed
pubmed-article:18366072pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18366072pubmed:citationSubsetIMlld:pubmed
pubmed-article:18366072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18366072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18366072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18366072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18366072pubmed:statusMEDLINElld:pubmed
pubmed-article:18366072pubmed:monthSeplld:pubmed
pubmed-article:18366072pubmed:issn1097-4652lld:pubmed
pubmed-article:18366072pubmed:authorpubmed-author:ChoiJe-YongJYlld:pubmed
pubmed-article:18366072pubmed:authorpubmed-author:KimHyun-NamHNlld:pubmed
pubmed-article:18366072pubmed:authorpubmed-author:JungYoun-Kwan...lld:pubmed
pubmed-article:18366072pubmed:authorpubmed-author:JeongJae-Hwan...lld:pubmed
pubmed-article:18366072pubmed:authorpubmed-author:JinJung-SukJSlld:pubmed
pubmed-article:18366072pubmed:authorpubmed-author:ParkNa-RaeNRlld:pubmed
pubmed-article:18366072pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18366072pubmed:volume216lld:pubmed
pubmed-article:18366072pubmed:ownerNLMlld:pubmed
pubmed-article:18366072pubmed:authorsCompleteYlld:pubmed
pubmed-article:18366072pubmed:pagination603-14lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:meshHeadingpubmed-meshheading:18366072...lld:pubmed
pubmed-article:18366072pubmed:year2008lld:pubmed
pubmed-article:18366072pubmed:articleTitleDICAM, a novel dual immunoglobulin domain containing cell adhesion molecule interacts with alphavbeta3 integrin.lld:pubmed
pubmed-article:18366072pubmed:affiliationDepartment of Biochemistry and Cell Biology, Kyungpook National University, Daegu, Republic of Korea.lld:pubmed
pubmed-article:18366072pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18366072pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:16410entrezgene:pubmedpubmed-article:18366072lld:entrezgene
entrez-gene:16416entrezgene:pubmedpubmed-article:18366072lld:entrezgene
entrez-gene:74761entrezgene:pubmedpubmed-article:18366072lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18366072lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18366072lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18366072lld:entrezgene